Dose capping enoxaparin is unjustified and denies patients with acute coronary syndromes a potentially effective treatment [9]

Sarah A. Spinler, Paul Dobesh

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Dose capping enoxaparin is unjustified and denies patients with acute coronary syndromes a potentially effective treatment [9]'. Together they form a unique fingerprint.